← Every company
Tempus AI Inc Patents
What Tempus AI Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
TEM on carbonthat →Filings on file
52
Granted
1
Still pending
51
Filed under
4 names
52 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| METHODS OF NORMALIZING AND CORRECTING RNA EXPRESSION DATAG16B 25/10, G16B 30/00, G06F 16/215, G16B 5/00, G16B 40/10, G16B 40/20Filed as TEMPUS AI, INC,2026-06-09Kaanan Shah | pending |
| Platform For Co-Culture Imaging To Characterize In Vitro Efficacy Of Heterotypic Effector Cellular Therapies In CancerG01N 21/6456, G01N 33/5082, G06T 7/12, G06T 7/11, G16H 15/00, G16H 50/70, G16H 50/20, G16H 20/10, G16H 30/40, G06V 20/695, G06V 20/698, G06V 10/32, G06V 10/82, G06V 10/774, G06V 10/46, G06V 20/69, G06T 3/06, G01N 21/6428, G01N 33/5011, G01N2021/6439, G06T 7/0016, G06T2200/04, G06T2207/10016, G06T2207/10024, G06T2207/10056, G06T2207/10064, G06T2207/20081, G06T2207/20084, G06T2207/30024, G06T2207/30072, G06T2207/30096Filed as TEMPUS AI, INC.2026-06-08Chi-Sing Ho | pending |
| SYSTEMS AND METHODS FOR CHARACTERIZING MUTATIONSG16B 30/10, G16B 20/20, G16B 40/20Filed as Tempus AI, Inc.2026-02-24Jerod R. Parsons | pending |
| MOBILE SUPPLEMENTATION, EXTRACTION, AND ANALYSIS OF HEALTH RECORDSG06Q 40/08, G16H 10/60, G16H 15/00, G16H 50/70, G16H 50/20, G16H 30/40, G06V 30/10, G06V 30/418, G06V 10/75, G06V 30/416, G06V 30/19013, G06F 18/217, G06F 18/2431Filed as TEMPUS AI, INC.2025-12-23Shane Colley | pending |
| PREDICTING LIKELIHOOD AND SITE OF METASTASIS FROM PATIENT RECORDSFiled as Tempus AI, Inc.2025-12-19Ashraf Hafez | pending |
| METHODS OF INTELLIGENTLY ROUTING PORTIONS OF A TASK THROUGH MULTIPLE CUSTOMIZED AGENTS, AND SYSTEMS AND DEVICES THEREFORG16H 40/20, G16H 50/20, G16H 70/00, G16H 10/60, G16H 15/00, G16H 50/30, G16H 30/00, G16H 10/20, G16H 70/20, G06F 9/453, G06N 20/00, G06F 16/3329, G06F 16/345, G06F 40/30, G06F 40/20, G06N 3/09, G06N 3/045, G06F 3/0482, G06F 8/34, G06F 21/31, G06N 3/105, G06Q 10/06316, G06Q 10/0633, H04L 63/083Filed as Tempus AI, Inc.2025-12-10Joshua Michael Bell | pending |
| SYSTEMS AND METHODS FOR PROVIDING RESPONSIVE MEDICAL DATA USING TASK-SPECIFIC ORCHESTRATIONSG16H 50/70, G16H 50/20, G16H 50/30, G16H 10/20, G06F 16/285, G06F 16/248Filed as Tempus AI, Inc.2025-11-26Daniel Max Banaszak | pending |
| Systems and Methods for Machine-Learning-Based Embedding and Clustering of Documents with Subsequent Action Ranking and NotificationG06F 16/906, G06F 16/383, G16H 40/67, G16H 10/60, G16H 15/00, G16H 50/70, G16H 50/20, G16H 30/40, G16H 40/63, G16H 10/20, G06F 16/35Filed as Tempus AI, Inc.2025-11-26Paul Fields | pending |
| METHODS AND SYSTEMS FOR CLASSIFYING CANCER AND DETECTING IMPROVED CANCER THERAPIESG16H 50/20, C12Q 1/6886, G16H 20/10, C12Q2600/112, C12Q2600/156, C12Q2600/158Filed as Tempus AI, Inc.2025-11-11Emma Tung Corcoran | pending |
| DATA BASED CANCER RESEARCH AND TREATMENT SYSTEMS AND METHODSG16H 10/40, G16H 10/60, G16H 20/40, G16H 50/50, G16H 15/00, G16H 50/30, G16H 50/70, G16H 50/20, G16H 20/10, G16H 30/40, G16B 40/00, G16B 20/00, G16B 25/00, G16B 40/20, G16B 30/00Filed as Tempus AI, Inc.2025-10-17Christopher Shane Colley | pending |
| DATA BASED CANCER RESEARCH AND TREATMENT SYSTEMS AND METHODSG16H 10/40, G16H 10/60, G16H 20/40, G16H 50/50, G16H 15/00, G16H 50/30, G16H 50/70, G16H 50/20, G16H 20/10, G16H 30/40, G16B 40/00, G16B 20/00, G16B 25/00, G16B 40/20, G16B 30/00Filed as Tempus AI, Inc.2025-10-17Christopher Shane Colley | pending |
| DATA BASED CANCER RESEARCH AND TREATMENT SYSTEMS AND METHODSG16H 10/40, G16H 10/60, G16H 20/40, G16H 50/50, G16H 15/00, G16H 50/30, G16H 50/70, G16H 50/20, G16H 20/10, G16H 30/40, G16B 40/00, G16B 20/00, G16B 25/00, G16B 40/20, G16B 30/00Filed as Tempus AI, Inc.2025-10-17Christopher Shane Colley | pending |
| DATA BASED CANCER RESEARCH AND TREATMENT SYSTEMS AND METHODSG16H 10/40, G16H 10/60, G16H 20/40, G16H 50/50, G16H 15/00, G16H 50/30, G16H 50/70, G16H 50/20, G16H 20/10, G16H 30/40, G16B 40/00, G16B 20/00, G16B 25/00, G16B 40/20, G16B 30/00Filed as Tempus AI, Inc.2025-10-16Christopher Shane Colley | pending |
| Determining Biomarkers from Histopathology Slide ImagesG06T 1/20, G06T 7/11, G06V 10/82, G06V2201/03, G06V 10/44, G06V 10/764, G06N 3/09, G06N 3/0895, G06F 18/21, G06N 3/045, G06N 3/0464, G06F 18/2431, G06N 3/084, G06T 7/0012, G06T 11/00, G06T2207/10024, G06T2207/10056, G06T2207/20081, G06T2207/20084, G06T2207/30024, G06T2207/30096Filed as TEMPUS AI, INC.2025-10-16Stephen Yip | pending |
| CLINICAL CONCEPT IDENTIFICATION, EXTRACTION, AND PREDICTION SYSTEM AND RELATED METHODSG16H 10/60, G16H 15/00, G16H 70/00, G16H 70/40, G16H 10/20, G06F 40/295, G06F 40/30, G06F 40/274, G06F 21/6254Filed as TEMPUS AI, INC.2025-10-09Michael Lucas | pending |
| SYSTEMS AND METHODS FOR PREDICTING THERAPEUTIC SENSITIVITYG16H 50/20, G01N 33/57515, G16B 40/20, G01N 33/57545, C12Q 1/6886, C12Q2600/106, G01N 33/5082Filed as Tempus AI, Inc.2025-09-18Madhavi Kannan | pending |
| DATA BASED CANCER RESEARCH AND TREATMENT SYSTEMS AND METHODSG16H 10/40, G16H 10/60, G16H 20/40, G16H 50/50, G16H 15/00, G16H 50/30, G16H 50/70, G16H 50/20, G16H 20/10, G16H 30/40, G16B 40/00, G16B 20/00, G16B 25/00, G16B 40/20, G16B 30/00Filed as Tempus AI, Inc.2025-08-18Christopher Shane Colley | pending |
| SYSTEMS AND METHODS FOR NEXT GENERATION SEQUENCING UNIFORM PROBE DESIGNC12Q 1/6874, C40B 40/06, C12Q 1/6883, C12Q 1/6886Filed as Tempus AI, Inc.2025-07-01Richard Blidner | pending |
| FUNCTIONAL BIOLOGICAL MODELING SYSTEMG16H 10/60, G16H 20/10, G16H 50/50, G16H 15/00, G16H 50/70, G16H 50/20Filed as Tempus AI, Inc.2025-06-30Christopher Shane Colley | pending |
| FUNCTIONAL BIOLOGICAL MODELING SYSTEMFiled as TEMPUS AI, INC.2025-06-30CHRISTOPHER SHANE COLLEY | pending |
| CANCER TREATMENT EFFICACY EVALUATION UPON UNDERGOING OR COMPLETING A CANCER TREATMENTG16H 50/70, G16H 10/60, G16H 50/20, G16H 20/00, G16B 50/30Filed as Tempus AI, Inc.2025-05-16Nike Tsiapera Beaubier | pending |
| METHODS AND SYSTEMS FOR TUMOR INFORMED CIRCULATING TUMOR FRACTION ESTIMATIONG16B 30/10, G16H 50/20, G16B 20/20, G16B 20/10, C12Q 1/6816, C12Q 1/6886, G01N2800/52Filed as Tempus AI, Inc.2025-03-26Terri M. Driessen | pending |
| ARTIFICIAL INTELLIGENCE ENGINE FOR DIRECTED HYPOTHESIS GENERATION AND RANKINGG06F 16/24578, G06N 5/041, G16H 50/70, G06F 16/284, G06N 3/0495, G06N 3/091, G06N 3/09, G06N 3/0455, G06N 3/0895, G06N 3/094, G06N 3/045, G06N 3/0464, G06N 3/092, G06N 3/096, G06N 3/0475, G06N 3/082, G06N 5/02Filed as Tempus AI, Inc.2025-02-28Martin Stumpe | pending |
| SYSTEMS AND METHODS FOR CHARACTERIZING MUTATIONSFiled as Tempus AI, Inc.2025-02-25Jerod R. Parsons | pending |
| DETECTING CARDIOVASCULAR CONDITION FROM ELECTROCARDIOGRAM DATA USING ENSEMBLE OF ARTIFICIAL INTELLIGENCE MODELSG16H 50/20, A61B 5/346, G16H 10/60, G16H 50/30, G16H 50/70, G16H 20/00, A61B 5/349, A61B 5/7264, A61B 5/7267, A61B 5/7275Filed as Tempus AI, Inc.2025-01-31Nicole Jane Rebecca Hakim | pending |
| DETECTING CARDIOVASCULAR CONDITION FROM ELECTROCARDIOGRAM DATA USING ENSEMBLE OF ARTIFICIAL INTELLIGENCE MODELSFiled as TEMPUS AI, INC.2025-01-31NICOLE JANE REBECCA HAKIM | pending |
| METHODS AND SYSTEMS FOR DETERMINING BLOOD TUMOR MUTATIONAL BURDEN IN A LIQUID BIOPSY ASSAYG16B 20/20, G16H 10/60, G16H 20/10, G16H 10/20, C12Q 1/6886Filed as Tempus AI, Inc.2025-01-30Terri M. Driessen | pending |
| AGENT ARCHITECTURE FOR PATIENT INTERACTIONFiled as Tempus AI, Inc.2025-01-20Daniel Max Banaszak | pending |
| SYSTEMS AND METHODS OF USING MULTIPLE MODALITIES OF DATA WITH MACHINE-LEARNING MODELSFiled as TEMPUS AI, INC.2024-12-31ABIGAIL MICHELLE LAMMERS | pending |
| SYSTEMS AND METHODS OF USING MULTIPLE MODALITIES OF DATA WITH MACHINE-LEARNING MODELSG16H 10/60, G16H 50/20, G16H 15/00, G16H 50/70, G06F 16/345Filed as Tempus AI, Inc.2024-12-30Erik T. Mueller | pending |
| COLLABORATIVE ARTIFICIAL INTELLIGENCE METHOD AND SYSTEMG06F 3/167, G10L 15/22, G16H 40/67, G16H 70/60, G16H 40/20, G16H 50/50, G16H 10/60, G16H 50/70, G16H 50/20, G16H 70/40, G16H 10/20, G16H 70/20, G06F 16/332, G06F 16/634, G06F 3/0481, G06N 5/022, G06N 5/041, G10L2015/223, H04B 1/3827Filed as Tempus AI, Inc.2024-12-11Eric Lefkofsky | pending |
| SYSTEMS AND METHODS FOR DETECTING SOMATIC VARIANTS DERIVED FROM CIRCULATING TUMOR NUCLEIC ACIDSFiled as TEMPUS AI, INC.2024-12-04KYLE ASHLEY BEAUCHAMP | pending |
| SYSTEMS AND METHODS FOR DETECTING SOMATIC VARIANTS DERIVED FROM CIRCULATING TUMOR NUCLEIC ACIDSG16B 20/20, C12Q 1/6886, G16B 30/10, G16B 20/00, G16B 40/20, C12Q2600/156Filed as Tempus AI, Inc.2024-12-04Kyle Ashley Beauchamp | pending |
| DIGITAL RESEARCH ASSISTANT AGENTFiled as Tempus AI, Inc.2024-11-27Ryan Fukushima | pending |
| AGENT ARCHITECTURE FOR PATIENT INTERACTIONFiled as Tempus AI, Inc.2024-11-27Daniel Max Banaszak | pending |
| METHODS AND SYSTEMS FOR STRATIFYING PATIENT CANCER RISK USING COMPUTATIONAL ONCOLOGY AND MOLECULAR DATAG16H 50/30, G16H 10/60Filed as TEMPUS AI, INC.2024-11-15Talal Ahmed | pending |
| METHODS AND SYSTEMS FOR DETERMINING HER2 STATUS USING MOLECULAR DATAG16B 40/20, G16H 10/40, G16H 15/00, G16H 20/10, A61B 10/0041, G16H 50/20, G16B 20/00Filed as TEMPUS AI, INC.2024-11-15Talal Ahmed | pending |
| METHODS AND SYSTEMS FOR CLASSIFYING CANCER AND DETECTING IMPROVED CANCER THERAPIESFiled as Tempus AI, Inc.2024-11-12Emma Tung Corcoran | pending |
| MOLECULAR RESPONSE AND PROGRESSION DETECTION FROM CIRCULATING CELL FREE DNAG16B 40/00, G16B 30/00, G16H 50/20, G16B 20/20, G16B 5/20, G16B 40/20, G06F2111/08, G06F 30/27Filed as Tempus AI, Inc.2024-11-05Justin David Finkle | pending |
| SYSTEMS AND METHODS FOR INTERROGATING CLINICAL DOCUMENTS FOR CHARACTERISTIC DATAG16H 10/60, G06Q 50/22, G16H 50/70, G16H 50/20, G16H 40/63, G16H 10/20, G06F 40/279, G06F 40/186, G06F 40/174Filed as TEMPUS AI, INC.2024-11-04Jonathan Ozeran | pending |
| PREDICTING TOTAL NUCLEIC ACID YIELD AND DISSECTION BOUNDARIES FOR HISTOLOGY SLIDESG06T 1/20, G16H 30/40, G16B 50/30, G16B 30/00, G06V 10/25, G06V 20/698, G06V 10/82, G06V2201/03, G06V 10/44, G06V 10/774, G06V 10/764, G06N 3/09, G06N 3/0895, G06N 3/045, G06N 3/0464, G06T 11/26, C12Q 1/6869, C12Q2535/101, G06N 3/084, G06T 7/0012, G06T2207/10024, G06T2207/10056, G06T2207/20081, G06T2207/20084, G06T2207/30024, G06T2207/30096Filed as TEMPUS AI, INC.2024-11-04Stephen Yip | pending |
| T CELL RECEPTOR SCREENING METHODSG16B 20/30, G16B 40/00, G16B 20/00, G16B 30/00, G16B 35/00, G01N 33/6845, G01N2333/7051Filed as Tempus AI, Inc.2024-10-31Paul Fields | pending |
| METHODS, SYSTEMS, AND COMPOSITIONS FOR PREDICTING RESPONSE TO IMMUNE ONCOLOGY THERAPIESG16H 50/20, G16H 20/10, G16B 20/00, G16B 40/20, G16B 30/00Filed as Tempus AI, Inc.2024-10-31Kyle A. Beauchamp | pending |
| ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCINGFiled as TEMPUS AI, INC.2024-10-29TERRI M. DRIESSEN | pending |
| ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCINGG16B 20/10, C12Q 1/6886, G16B 20/20, G16B 40/20, G16B 30/00, C12Q 1/6874Filed as Tempus AI, Inc.2024-10-29Terri M. Driessen | pending |
| SYSTEMS AND METHODS OF STRUCTURING AND QUERYING SUBJECT DATAFiled as Tempus AI, Inc.2024-10-25Abigail Michelle Lammers | pending |
| TCR/BCR PROFILINGC12Q 1/6869, C12Q 1/6883, C07K 14/7051, C12N2501/515, C12N2502/1114, C12Q 1/6806, C12Q 1/6813, C12Q 1/6876, C12Q 1/6881, C12Q 1/6886, C12Q2600/106, C12Q2600/118, C12Q2600/158, G01N2800/26, C12Q2535/122, C12Q2565/519Filed as Tempus AI, Inc.2024-10-23Jason Perera | pending |
| SYSTEMS AND METHODS FOR MOLECULAR RESIDUAL DISEASE LIQUID BIOPSY ASSAYFiled as TEMPUS AI, INC.2024-10-11ANA SOFIA DE OLAZARRA | pending |
| SYSTEMS AND METHODS FOR MOLECULAR RESIDUAL DISEASE LIQUID BIOPSY ASSAYG16H 50/20, C12Q 1/6886, G16H 20/10, G16B 20/20, G16B 20/00, G16B 20/10, G16B 40/20, C12Q2600/154Filed as Tempus AI, Inc.2024-10-11Ana Sofia de Olazarra | pending |
| PREDICTING UNOBSERVED QUANTITATIVE MEASURES USING MACHINE LEARNINGG16H 10/40, G16C 20/30, G16H 30/40, G16C 20/70, G06T 3/4046Filed as TEMPUS AI, INC.2024-09-04Chi-Sing Ho | pending |
| DETECTING LOW EJECTION FRACTION FROM ELECTROCARDIOGRAM DATA USING ARTIFICIAL INTELLIGENCEFiled as TEMPUS AI, INC.2024-08-30NICOLE JANE REBECCA HAKIM | pending |
| DETECTING LOW EJECTION FRACTION FROM ELECTROCARDIOGRAM DATA USING ARTIFICIAL INTELLIGENCEG16H 50/30, A61B 8/5284, G16H 50/70, G16H 50/20, A61B 8/065, A61B 8/5223Filed as Tempus AI, Inc.2024-08-30Nicole Jane Rebecca Hakim | 12727863 |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on TEM
Company overviewEverything on TEM in one place, with the price.SEC filingsWhat TEM's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat TEM's own officers and directors buy and sell.Planned salesSales TEM insiders have filed notice of.Executive payWhat TEM awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in TEM.Funds holding itWhich funds and ETFs hold TEM, and how big a bet.LobbyingWhat TEM spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on TEM's account, and who they worked for.Federal contractsWhat federal agencies pay TEM.